nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.048	0.21	CbGbCtD
Mianserin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.039	0.171	CbGbCtD
Mianserin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0296	0.129	CbGbCtD
Mianserin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0254	0.111	CbGbCtD
Mianserin—CYP3A4—Prednisolone—ankylosing spondylitis	0.025	0.11	CbGbCtD
Mianserin—CYP3A4—Prednisone—ankylosing spondylitis	0.0236	0.103	CbGbCtD
Mianserin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0232	0.102	CbGbCtD
Mianserin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0148	0.0646	CbGbCtD
Mianserin—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.0137	0.0178	CcSEcCtD
Mianserin—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.0125	0.0162	CcSEcCtD
Mianserin—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.0125	0.0162	CcSEcCtD
Mianserin—Suicidal ideation—Prednisone—ankylosing spondylitis	0.0109	0.0141	CcSEcCtD
Mianserin—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.00945	0.0123	CcSEcCtD
Mianserin—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00725	0.0094	CcSEcCtD
Mianserin—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00717	0.00929	CcSEcCtD
Mianserin—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00675	0.00874	CcSEcCtD
Mianserin—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00667	0.00864	CcSEcCtD
Mianserin—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00666	0.00863	CcSEcCtD
Mianserin—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00665	0.00862	CcSEcCtD
Mianserin—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00652	0.00845	CcSEcCtD
Mianserin—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00652	0.00845	CcSEcCtD
Mianserin—Lethargy—Betamethasone—ankylosing spondylitis	0.00649	0.00842	CcSEcCtD
Mianserin—Lethargy—Dexamethasone—ankylosing spondylitis	0.00649	0.00842	CcSEcCtD
Mianserin—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00632	0.0082	CcSEcCtD
Mianserin—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00605	0.00784	CcSEcCtD
Mianserin—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00605	0.00784	CcSEcCtD
Mianserin—Weight increased—Prednisolone—ankylosing spondylitis	0.006	0.00778	CcSEcCtD
Mianserin—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00571	0.0074	CcSEcCtD
Mianserin—Cardiac failure—Prednisone—ankylosing spondylitis	0.00568	0.00736	CcSEcCtD
Mianserin—Lethargy—Prednisone—ankylosing spondylitis	0.00566	0.00733	CcSEcCtD
Mianserin—Weight increased—Triamcinolone—ankylosing spondylitis	0.00552	0.00715	CcSEcCtD
Mianserin—Weight increased—Methylprednisolone—ankylosing spondylitis	0.0055	0.00713	CcSEcCtD
Mianserin—Bradycardia—Prednisolone—ankylosing spondylitis	0.00537	0.00696	CcSEcCtD
Mianserin—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00527	0.00683	CcSEcCtD
Mianserin—Weight increased—Betamethasone—ankylosing spondylitis	0.00501	0.00649	CcSEcCtD
Mianserin—Weight increased—Dexamethasone—ankylosing spondylitis	0.00501	0.00649	CcSEcCtD
Mianserin—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00494	0.0064	CcSEcCtD
Mianserin—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00493	0.00639	CcSEcCtD
Mianserin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00476	0.00617	CcSEcCtD
Mianserin—Lethargy—Methotrexate—ankylosing spondylitis	0.00473	0.00613	CcSEcCtD
Mianserin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00452	0.00586	CcSEcCtD
Mianserin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00449	0.00582	CcSEcCtD
Mianserin—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00448	0.00581	CcSEcCtD
Mianserin—Bradycardia—Betamethasone—ankylosing spondylitis	0.00448	0.00581	CcSEcCtD
Mianserin—Neutropenia—Prednisone—ankylosing spondylitis	0.00448	0.00581	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00441	0.00572	CcSEcCtD
Mianserin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00439	0.00569	CcSEcCtD
Mianserin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00436	0.00565	CcSEcCtD
Mianserin—Weight increased—Prednisone—ankylosing spondylitis	0.00436	0.00565	CcSEcCtD
Mianserin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00424	0.0055	CcSEcCtD
Mianserin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00419	0.00542	CcSEcCtD
Mianserin—Vertigo—Prednisolone—ankylosing spondylitis	0.00413	0.00535	CcSEcCtD
Mianserin—Syncope—Prednisolone—ankylosing spondylitis	0.00412	0.00534	CcSEcCtD
Mianserin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00411	0.00533	CcSEcCtD
Mianserin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00411	0.00533	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00404	0.00523	CcSEcCtD
Mianserin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00399	0.00518	CcSEcCtD
Mianserin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00399	0.00518	CcSEcCtD
Mianserin—Convulsion—Prednisolone—ankylosing spondylitis	0.00398	0.00516	CcSEcCtD
Mianserin—Hypertension—Prednisolone—ankylosing spondylitis	0.00397	0.00514	CcSEcCtD
Mianserin—Bradycardia—Prednisone—ankylosing spondylitis	0.0039	0.00506	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.0038	0.00493	CcSEcCtD
Mianserin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00379	0.00492	CcSEcCtD
Mianserin—Syncope—Triamcinolone—ankylosing spondylitis	0.00379	0.00491	CcSEcCtD
Mianserin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00379	0.00491	CcSEcCtD
Mianserin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00378	0.0049	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00377	0.00488	CcSEcCtD
Mianserin—Oedema—Prednisolone—ankylosing spondylitis	0.00375	0.00486	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—ankylosing spondylitis	0.00374	0.00485	CcSEcCtD
Mianserin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00371	0.00481	CcSEcCtD
Mianserin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0037	0.0048	CcSEcCtD
Mianserin—Shock—Prednisolone—ankylosing spondylitis	0.00369	0.00478	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00369	0.00478	CcSEcCtD
Mianserin—Convulsion—Triamcinolone—ankylosing spondylitis	0.00366	0.00474	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00366	0.00474	CcSEcCtD
Mianserin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00365	0.00473	CcSEcCtD
Mianserin—Hypertension—Triamcinolone—ankylosing spondylitis	0.00365	0.00473	CcSEcCtD
Mianserin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00364	0.00472	CcSEcCtD
Mianserin—Myalgia—Triamcinolone—ankylosing spondylitis	0.0036	0.00466	CcSEcCtD
Mianserin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00359	0.00465	CcSEcCtD
Mianserin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00359	0.00465	CcSEcCtD
Mianserin—Eye disorder—Prednisone—ankylosing spondylitis	0.00358	0.00464	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—ankylosing spondylitis	0.00357	0.00463	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00356	0.00462	CcSEcCtD
Mianserin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00352	0.00456	CcSEcCtD
Mianserin—Angiopathy—Prednisone—ankylosing spondylitis	0.00348	0.00451	CcSEcCtD
Mianserin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00347	0.00449	CcSEcCtD
Mianserin—Oedema—Triamcinolone—ankylosing spondylitis	0.00345	0.00447	CcSEcCtD
Mianserin—Vertigo—Betamethasone—ankylosing spondylitis	0.00344	0.00446	CcSEcCtD
Mianserin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00344	0.00446	CcSEcCtD
Mianserin—Syncope—Betamethasone—ankylosing spondylitis	0.00344	0.00445	CcSEcCtD
Mianserin—Syncope—Dexamethasone—ankylosing spondylitis	0.00344	0.00445	CcSEcCtD
Mianserin—Shock—Triamcinolone—ankylosing spondylitis	0.00339	0.0044	CcSEcCtD
Mianserin—Shock—Methylprednisolone—ankylosing spondylitis	0.00338	0.00439	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00338	0.00438	CcSEcCtD
Mianserin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00337	0.00437	CcSEcCtD
Mianserin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00337	0.00437	CcSEcCtD
Mianserin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00337	0.00437	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00337	0.00436	CcSEcCtD
Mianserin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00336	0.00436	CcSEcCtD
Mianserin—Mental disorder—Prednisone—ankylosing spondylitis	0.00336	0.00435	CcSEcCtD
Mianserin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00336	0.00435	CcSEcCtD
Mianserin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00334	0.00433	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00333	0.00432	CcSEcCtD
Mianserin—Convulsion—Dexamethasone—ankylosing spondylitis	0.00332	0.0043	CcSEcCtD
Mianserin—Convulsion—Betamethasone—ankylosing spondylitis	0.00332	0.0043	CcSEcCtD
Mianserin—Hypertension—Betamethasone—ankylosing spondylitis	0.00331	0.00429	CcSEcCtD
Mianserin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00331	0.00429	CcSEcCtD
Mianserin—Myalgia—Dexamethasone—ankylosing spondylitis	0.00326	0.00423	CcSEcCtD
Mianserin—Myalgia—Betamethasone—ankylosing spondylitis	0.00326	0.00423	CcSEcCtD
Mianserin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00321	0.00417	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—ankylosing spondylitis	0.0032	0.00415	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00314	0.00407	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00313	0.00406	CcSEcCtD
Mianserin—Oedema—Betamethasone—ankylosing spondylitis	0.00313	0.00405	CcSEcCtD
Mianserin—Oedema—Dexamethasone—ankylosing spondylitis	0.00313	0.00405	CcSEcCtD
Mianserin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0031	0.00401	CcSEcCtD
Mianserin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00309	0.004	CcSEcCtD
Mianserin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00309	0.004	CcSEcCtD
Mianserin—Anaemia—Prednisone—ankylosing spondylitis	0.00308	0.004	CcSEcCtD
Mianserin—Shock—Dexamethasone—ankylosing spondylitis	0.00308	0.00399	CcSEcCtD
Mianserin—Shock—Betamethasone—ankylosing spondylitis	0.00308	0.00399	CcSEcCtD
Mianserin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00307	0.00398	CcSEcCtD
Mianserin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00307	0.00398	CcSEcCtD
Mianserin—Agitation—Prednisone—ankylosing spondylitis	0.00307	0.00398	CcSEcCtD
Mianserin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00306	0.00397	CcSEcCtD
Mianserin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00306	0.00397	CcSEcCtD
Mianserin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00305	0.00396	CcSEcCtD
Mianserin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00305	0.00396	CcSEcCtD
Mianserin—Vertigo—Prednisone—ankylosing spondylitis	0.003	0.00389	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00299	0.00388	CcSEcCtD
Mianserin—Syncope—Prednisone—ankylosing spondylitis	0.00299	0.00388	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—ankylosing spondylitis	0.00299	0.00387	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00297	0.00385	CcSEcCtD
Mianserin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00297	0.00385	CcSEcCtD
Mianserin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00297	0.00384	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00293	0.0038	CcSEcCtD
Mianserin—Hypotension—Betamethasone—ankylosing spondylitis	0.00292	0.00379	CcSEcCtD
Mianserin—Hypotension—Dexamethasone—ankylosing spondylitis	0.00292	0.00379	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00291	0.00377	CcSEcCtD
Mianserin—Convulsion—Prednisone—ankylosing spondylitis	0.00289	0.00375	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00289	0.00374	CcSEcCtD
Mianserin—Hypertension—Prednisone—ankylosing spondylitis	0.00288	0.00373	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00285	0.00369	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00285	0.00369	CcSEcCtD
Mianserin—Arthralgia—Prednisone—ankylosing spondylitis	0.00284	0.00368	CcSEcCtD
Mianserin—Myalgia—Prednisone—ankylosing spondylitis	0.00284	0.00368	CcSEcCtD
Mianserin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00284	0.00368	CcSEcCtD
Mianserin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00283	0.00367	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00282	0.00366	CcSEcCtD
Mianserin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00281	0.00364	CcSEcCtD
Mianserin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00281	0.00364	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00281	0.00364	CcSEcCtD
Mianserin—Oedema—Prednisone—ankylosing spondylitis	0.00272	0.00353	CcSEcCtD
Mianserin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0027	0.0035	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0027	0.0035	CcSEcCtD
Mianserin—Fatigue—Dexamethasone—ankylosing spondylitis	0.0027	0.0035	CcSEcCtD
Mianserin—Fatigue—Betamethasone—ankylosing spondylitis	0.0027	0.0035	CcSEcCtD
Mianserin—Shock—Prednisone—ankylosing spondylitis	0.00268	0.00347	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00267	0.00346	CcSEcCtD
Mianserin—Tachycardia—Prednisone—ankylosing spondylitis	0.00266	0.00345	CcSEcCtD
Mianserin—Skin disorder—Prednisone—ankylosing spondylitis	0.00265	0.00343	CcSEcCtD
Mianserin—Anaemia—Methotrexate—ankylosing spondylitis	0.00258	0.00334	CcSEcCtD
Mianserin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00258	0.00334	CcSEcCtD
Mianserin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00258	0.00334	CcSEcCtD
Mianserin—Vertigo—Methotrexate—ankylosing spondylitis	0.00251	0.00325	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—ankylosing spondylitis	0.0025	0.00324	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00248	0.00322	CcSEcCtD
Mianserin—Dizziness—Prednisolone—ankylosing spondylitis	0.00248	0.00321	CcSEcCtD
Mianserin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00247	0.00321	CcSEcCtD
Mianserin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00247	0.0032	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—ankylosing spondylitis	0.00245	0.00317	CcSEcCtD
Mianserin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00244	0.00316	CcSEcCtD
Mianserin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00243	0.00315	CcSEcCtD
Mianserin—Convulsion—Methotrexate—ankylosing spondylitis	0.00242	0.00313	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00237	0.00308	CcSEcCtD
Mianserin—Myalgia—Methotrexate—ankylosing spondylitis	0.00237	0.00308	CcSEcCtD
Mianserin—Rash—Prednisolone—ankylosing spondylitis	0.00236	0.00306	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00236	0.00306	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00236	0.00306	CcSEcCtD
Mianserin—Fatigue—Prednisone—ankylosing spondylitis	0.00235	0.00304	CcSEcCtD
Mianserin—Headache—Prednisolone—ankylosing spondylitis	0.00235	0.00304	CcSEcCtD
Mianserin—Constipation—Prednisone—ankylosing spondylitis	0.00233	0.00302	CcSEcCtD
Mianserin—Confusional state—Methotrexate—ankylosing spondylitis	0.0023	0.00297	CcSEcCtD
Mianserin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00228	0.00295	CcSEcCtD
Mianserin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00227	0.00295	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00224	0.00291	CcSEcCtD
Mianserin—Asthenia—Betamethasone—ankylosing spondylitis	0.00224	0.00291	CcSEcCtD
Mianserin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00224	0.00291	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00223	0.00289	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00223	0.00289	CcSEcCtD
Mianserin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00221	0.00287	CcSEcCtD
Mianserin—Pruritus—Betamethasone—ankylosing spondylitis	0.00221	0.00287	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00221	0.00287	CcSEcCtD
Mianserin—Rash—Triamcinolone—ankylosing spondylitis	0.00217	0.00282	CcSEcCtD
Mianserin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00217	0.00281	CcSEcCtD
Mianserin—Rash—Methylprednisolone—ankylosing spondylitis	0.00217	0.00281	CcSEcCtD
Mianserin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00217	0.00281	CcSEcCtD
Mianserin—Headache—Triamcinolone—ankylosing spondylitis	0.00216	0.0028	CcSEcCtD
Mianserin—Headache—Methylprednisolone—ankylosing spondylitis	0.00215	0.00279	CcSEcCtD
Mianserin—Hypotension—Methotrexate—ankylosing spondylitis	0.00213	0.00276	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00207	0.00269	CcSEcCtD
Mianserin—Dizziness—Betamethasone—ankylosing spondylitis	0.00207	0.00268	CcSEcCtD
Mianserin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00207	0.00268	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00204	0.00265	CcSEcCtD
Mianserin—Somnolence—Methotrexate—ankylosing spondylitis	0.00202	0.00262	CcSEcCtD
Mianserin—Rash—Dexamethasone—ankylosing spondylitis	0.00197	0.00256	CcSEcCtD
Mianserin—Rash—Betamethasone—ankylosing spondylitis	0.00197	0.00256	CcSEcCtD
Mianserin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00197	0.00255	CcSEcCtD
Mianserin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00197	0.00255	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00197	0.00255	CcSEcCtD
Mianserin—Fatigue—Methotrexate—ankylosing spondylitis	0.00196	0.00254	CcSEcCtD
Mianserin—Headache—Betamethasone—ankylosing spondylitis	0.00196	0.00254	CcSEcCtD
Mianserin—Headache—Dexamethasone—ankylosing spondylitis	0.00196	0.00254	CcSEcCtD
Mianserin—Asthenia—Prednisone—ankylosing spondylitis	0.00195	0.00253	CcSEcCtD
Mianserin—Pruritus—Prednisone—ankylosing spondylitis	0.00193	0.0025	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00188	0.00243	CcSEcCtD
Mianserin—Dizziness—Prednisone—ankylosing spondylitis	0.0018	0.00233	CcSEcCtD
Mianserin—Rash—Prednisone—ankylosing spondylitis	0.00172	0.00223	CcSEcCtD
Mianserin—Dermatitis—Prednisone—ankylosing spondylitis	0.00172	0.00222	CcSEcCtD
Mianserin—Headache—Prednisone—ankylosing spondylitis	0.00171	0.00221	CcSEcCtD
Mianserin—Asthenia—Methotrexate—ankylosing spondylitis	0.00163	0.00212	CcSEcCtD
Mianserin—Pruritus—Methotrexate—ankylosing spondylitis	0.00161	0.00209	CcSEcCtD
Mianserin—Dizziness—Methotrexate—ankylosing spondylitis	0.00151	0.00195	CcSEcCtD
Mianserin—Rash—Methotrexate—ankylosing spondylitis	0.00144	0.00186	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00143	0.00186	CcSEcCtD
Mianserin—Headache—Methotrexate—ankylosing spondylitis	0.00143	0.00185	CcSEcCtD
